These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28933754)

  • 1. The Positive Correlation of the Enhanced Immune Response to PCV2 Subunit Vaccine by Conjugation of Chitosan Oligosaccharide with the Deacetylation Degree.
    Zhang G; Cheng G; Jia P; Jiao S; Feng C; Hu T; Liu H; Du Y
    Mar Drugs; 2017 Jul; 15(8):. PubMed ID: 28933754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immune response to inactivated porcine circovirus type 2 (PCV2) vaccine by conjugation of chitosan oligosaccharides.
    Zhang G; Jia P; Cheng G; Jiao S; Ren L; Ji S; Hu T; Liu H; Du Y
    Carbohydr Polym; 2017 Jun; 166():64-72. PubMed ID: 28385249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of chitosan oligosaccharides via a carrier protein markedly improves immunogenicity of porcine circovirus vaccine.
    Zhang G; Jia P; Liu H; Hu T; Du Y
    Glycoconj J; 2018 Oct; 35(5):451-459. PubMed ID: 30051156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of chitosan oligosaccharides enhances immune response to porcine circovirus vaccine by activating macrophages.
    Zhang G; Jia P; Liu H; Hu T; Du Y
    Immunobiology; 2018 Nov; 223(11):663-670. PubMed ID: 30005969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 Ligand and GMCSF Coexpression Enhance the Immune Responses and Protective Efficacy of PCV2 Adenovirus Vaccine.
    Li D; Huang Y; Du Q; Wang Z; Chang L; Zhao X; Tong D
    Viral Immunol; 2016 Apr; 29(3):148-58. PubMed ID: 26982652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the Immunogenicity of Porcine Circovirus Type 2 DNA Vaccine by Recombinant ORF2 Gene and CpG Motifs.
    Li J; Shi JL; Wu XY; Fu F; Yu J; Yuan XY; Peng Z; Cong XY; Xu SJ; Sun WB; Cheng KH; Du YJ; Wu JQ; Wang JB; Huang BH
    Viral Immunol; 2015 Jun; 28(5):290-6. PubMed ID: 26046831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
    Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
    BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.
    Koinig HC; Talker SC; Stadler M; Ladinig A; Graage R; Ritzmann M; Hennig-Pauka I; Gerner W; Saalmüller A
    Vet Res; 2015 Mar; 46():20. PubMed ID: 25888899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
    Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
    Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration.
    Bucarey SA; Pujol M; Poblete J; Nuñez I; Tapia CV; Neira-Carrillo A; Martinez J; Bassa O
    Virol J; 2014 Aug; 11():149. PubMed ID: 25141864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine circovirus type 2 capsid protein and interleukin 18.
    Zheng LL; Guo XQ; Zhu QL; Chao AJ; Fu PF; Wei ZY; Wang SJ; Chen HY; Cui BA
    Virus Res; 2015 Apr; 201():8-15. PubMed ID: 25701744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
    Li PC; Qiao XW; Zheng QS; Hou JB
    Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of porcine circovirus 2 (PCV2) open reading frame 2 DNA vaccine with different adjuvants and comparison with commercial PCV2 subunit vaccine in an experimental challenge.
    Park C; Jeong J; Choi K; Park SJ; Kang I; Chae C
    Can J Vet Res; 2017 Jul; 81(3):171-177. PubMed ID: 28725106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.